REVIEW
Add like
Add dislike
Add to saved papers

Laser therapy of giant congenital melanocytic nevi.

Giant congenital melanocytic nevi (GCMN) are rare disfiguring potentially malignant lesions present at birth. The approach of these patients is based on two main considerations: attempt to minimize the risk of malignancy, and obtain an acceptable cosmetic result. Sometimes they are too large to be removed by multiple surgical excision or by use of osmotic expander. The objective of treatment of giant congenital nevi is to obtain ablation without side effects or after-effects from aesthetics. But for the moment such treatment doesn't exist. The aim of this review was to access treatment of GCMN with lasers as an alternative to surgery. Lasers should only be regarded as a treatment option for GCMN that cannot be surgically excised. For the moment laser therapy of GCMN should be restricted to well controlled studies or to individual patients in whom surgical procedures are not possible or would result in unacceptable scarring. Today ultrashort high energy pulsed CO2 laser and the normal mode ruby laser are the two lasers available. But the results are too unforeseeable, and painful with these two lasers. The combined use of normal mode and Q-switched ruby lasers or ultrashort high energy pulsed CO2 laser and Q-switched ruby or Nd:YAG lasers can give us a solution. In the future perhaps new Q-switched laser could give us a better way of treatment, with less pain, and no scars. We need an improvement of the technology in this field and hopefully the picosecond systems will be available in the future.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app